Warning: The NCBI web site requires JavaScript to function. more...
Cancerous stem cells: deviant stem cells with cancer-causing misbehavior.
Chandler JM, Lagasse E.
Stem Cell Res Ther. 2010 May 20;1(2):13.
Related citations
Selective targeting of cancer stem cells: a new concept in cancer therapeutics.
Korkaya H, Wicha MS.
BioDrugs. 2007;21(5):299-310. Review.
PTEN, stem cells, and cancer stem cells.
Hill R, Wu H.
J Biol Chem. 2009 May 1;284(18):11755-9. Epub 2008 Dec 30. Review.
Normal stem cells and cancer stem cells: the niche matters.
Li L, Neaves WB.
Cancer Res. 2006 May 1;66(9):4553-7. Review. Erratum in: Cancer Res. 2006 Jun 15;66(12):6458.
Tumor-initiating and -propagating cells: cells that we would like to identify and control.
Tysnes BB.
Neoplasia. 2010 Jul;12(7):506-15. Review.
Stem cells in gastrointestinal cancers: a matter of choice in cell fate determination.
Wei B, Chen L, Li R, Tian J.
Expert Rev Anticancer Ther. 2010 Oct;10(10):1621-33. Review. Erratum in: Expert Rev Anticancer Ther. 2010 Nov;10(11):1854.
Adult stem cells and cancer stem cells: tie in or tear apart?
Liu BB, Qin LX, Liu YK.
J Cancer Res Clin Oncol. 2005 Oct;131(10):631-8. Epub 2005 Oct 20. Review.
Maturation arrest of stem cell differentiation is a common pathway for the cellular origin of teratocarcinomas and epithelial cancers.
Sell S, Pierce GB.
Lab Invest. 1994 Jan;70(1):6-22. Review.
Pancreatic cancer stem cells: new understanding of tumorigenesis, clinical implications.
Ischenko I, Seeliger H, Kleespies A, Angele MK, Eichhorn ME, Jauch KW, Bruns CJ.
Langenbecks Arch Surg. 2010 Jan;395(1):1-10. Epub 2009 May 7. Review.
WNT signaling regulates self-renewal and differentiation of prostate cancer cells with stem cell characteristics.
Bisson I, Prowse DM.
Cell Res. 2009 Jun;19(6):683-97.
The biology of cancer stem cells.
Lobo NA, Shimono Y, Qian D, Clarke MF.
Annu Rev Cell Dev Biol. 2007;23:675-99. Review.
Stem cell therapies to treat muscular dystrophy: progress to date.
Meregalli M, Farini A, Parolini D, Maciotta S, Torrente Y.
BioDrugs. 2010 Aug 1;24(4):237-47. doi: 10.2165/11534300-000000000-00000. Review.
Oncogenes, self-renewal and cancer.
Clarke MF.
Pathol Biol (Paris). 2006 Mar;54(2):109-11. Epub 2006 Mar 9. Review.
New advances on critical implications of tumor- and metastasis-initiating cells in cancer progression, treatment resistance and disease recurrence.
Mimeault M, Batra SK.
Histol Histopathol. 2010 Aug;25(8):1057-73. Review.
MicroRNA reins in embryonic and cancer stem cells.
Mallick B, Chakrabarti J, Ghosh Z.
RNA Biol. 2011 May-Jun;8(3):415-26. Epub 2011 May 1.
Targeting cancer stem cells for more effective therapies: Taking out cancer's locomotive engine.
Winquist RJ, Boucher DM, Wood M, Furey BF.
Biochem Pharmacol. 2009 Aug 15;78(4):326-34. Epub 2009 Apr 1.
Pancreatic cancer stem cells.
Lee CJ, Dosch J, Simeone DM.
J Clin Oncol. 2008 Jun 10;26(17):2806-12. Review.
No small matter: microRNAs - key regulators of cancer stem cells.
Ji Q, Karnak D, Hao P, Wang R, Xu L.
Int J Clin Exp Med. 2010 Mar 12;3(1):84-7.
Emerging drug discovery approaches for selective targeting of "precursor" metastatic breast cancer cells: highlights and perspectives.
Aalaoui-Jamali M, Bijian K, Batist G.
Am J Transl Res. 2011;3(5):434-44. Epub 2011 Sep 8.
Redox regulation and its emerging roles in stem cells and stem-like cancer cells.
Ogasawara MA, Zhang H.
Antioxid Redox Signal. 2009 May;11(5):1107-22. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on